naloxone on a wheat-free diet—has not been studied. (Clinical studies that might lead to conclusions that don’t support drug use are often not performed. In this case, had naloxone shown benefit in wheat-consuming schizophrenics, the unavoidable conclusion would have been to eliminate wheat, not prescribe the drug.)
The schizophrenia experience shows us that wheat exorphins have the potential to exert distinct effects on the brain. Those of us without schizophrenia don’t experience auditory hallucinations from exorphins resulting from an onion bagel, but these compounds are still there in the brain, no different than in a schizophrenic. It also highlights how wheat is truly unique among grains, since other grains such as millet and flax do not generate exor-phins (since they lack gluten), nor do they cultivate obsessive behavior or withdrawal in people with normal brains or people with abnormal brains.
So this is your brain on wheat: Digestion yields morphinelike compounds that bind to the brain’s opiate receptors. It induces a form of reward, a mild euphoria. When the effect is blocked or no exorphin-yielding foods are consumed, some people experience a distinctly unpleasant withdrawal.
What happens if normal (i.e., nonschizophrenic) humans are given opiate-blocking drugs? In a study conducted at the Psychiatric Institute of the University of South Carolina, wheat-consuming participants given naloxone consumed 33 percent fewer calories at lunch and 23 percent fewer calories at dinner (a total of approximately 400 calories less over the two meals) than participants given a placebo. 13 At the University of Michigan, binge eaters were confined to a room filled with food for one hour. (There’s an idea for a new TV show:
The Biggest Gainer)
Participants consumed 28 percent less wheat crackers, bread sticks, and pretzels with administration of naloxone. 14
In other words, block the euphoric reward of wheat and calorie intake goes down, since wheat no longer generates the favorable feelings that encourage repetitive consumption. (Predictably, this strategy is being pursued by the pharmaceutical industry to commercialize a weight loss drug that contains naltrexone, an oral equivalent to naloxone. The drug is purported to block the meso-limbic reward system buried deep within the human brain that is responsible for generating pleasurable feelings from heroin, morphine, and other substances. Pleasurable feelings can be replaced by feelings of dysphoria, or unhappiness. Naltrexone will therefore be combined with the antidepressant and smoking cessation drug bupropion.)
From withdrawal effects to psychotic hallucinations, wheat is party to some peculiar neurological phenomena. To recap:
Common wheat, upon digestion, yields polypeptides that possess the ability to cross into the brain and bind to opiate receptors.
The action of wheat-derived polypeptides, the so-called exorphins such as gluteomorphin, can be short-circuited with the opiate-blocking drugs naloxone and naltrexone.
When administered to normal people or people with uncontrollable appetite, opiate-blocking drugs yield reductions in appetite, cravings, and calorie intake, as well as dampen mood, and the effect seems particularly specific to wheat-containing products.
Wheat, in fact, nearly stands alone as a food with potent central nervous system effects. Outside of intoxicants such as ethanol (like that in your favorite merlot or chardonnay), wheat is one of the few foods that can alter behavior, induce pleasurable effects, and generate a withdrawal syndrome upon its removal. And it required observations in schizophrenic patients to teach us about these effects.
NIGHT CRAVINGS CONQUERED
For as long as he could remember, Larry struggled with weight.
It never made sense to him: He exercised, often to extremes. A 50-mile bike ride was not unusual, nor was a 15-mile walk in the woods or desert. As part of his work, Larry enjoyed the terrain of many different
John McEnroe;James Kaplan
Abby Green
D. J. Molles
Amy Jo Cousins
Oliver Strange
T.A. Hardenbrook
Ben Peek
Victoria Barry
William K. Klingaman, Nicholas P. Klingaman
Simon Brett